查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1870487

Erucamide市場：按應用、終端用戶產業、產品類型和技術分類－2025-2032年全球預測

Erucamide Market by Application, End Use Industry, Product Type, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，Erucamide市場規模將成長至 3.8539 億美元，複合年成長率為 4.33%。

關鍵市場統計數據
基準年 2024 2.7442億美元
預計年份：2025年 2.8658億美元
預測年份 2032 3.8539億美元
複合年成長率 (%) 4.33%

簡明扼要地介紹了Erucamide的化學性質、工業效用、加工注意事項以及決策者採取明智行動所需的實用框架。

Erucamide已成為聚合物、潤滑劑和表面改質劑中重要的爽滑劑和加工助劑，在製造業領域有著廣泛的應用。本執行摘要闡述了Erucamide在現代生產環境中的作用，重點介紹了其理化性質、與聚烯的相容性以及在改善表面觸感、摩擦性能和加工穩定性方面的效用。讀者將清楚了解Erucamide在價值鏈中的定位、它如何與常用樹脂系統相互作用，以及為什麼其規格和採購越來越受到材料工程師和採購負責人的關注。

原料來源的演變、永續性優先事項的調整、監管政策的變化以及加工流程的創新正在重新定義Erucamide的應用和供應鏈策略。

隨著原物料採購管道、永續性優先事項和下游配方偏好同步演變，Erucamide市場格局正在迅速變化。在整個價值鏈中，原料採購策略正在調整以應對日益嚴格的原料價格波動和生命週期影響審查，這迫使配方師重新評估添加劑的性能標準，並要求供應商提高可追溯性。加工技術和複合技術的進步正在拓展Erucamide的應用範圍，使其超越傳統的潤滑劑應用，從而改善低溫遷移控制並提高與先進聚烯共混物的相容性。

2025年美國關稅調整對添加劑供應鏈採購行為、供應商多角化與庫存策略的影響

2025年美國關稅調整對籌資策略、供應商選擇和供應鏈緊急時應對計畫產生了實際的影響。進口關稅改變了出口商的相對到岸成本差異，使得採購談判的重點轉向國內製造業的韌性和多元化的供應商網路。因此，買家重新評估了長期的供應商關係，並加快了二級資訊訂購流程，以確保供應的連續性。

可操作的細分分析揭示了應用、最終用途產業、產品類型和生產技術如何決定Erucamide的適用性和供應商選擇。

細分市場分析揭示了影響Erucamide選擇和配方策略的具體應用因素和技術要求。在應用領域內，電纜電線、擠出成型、射出成型和包裝薄膜的市場動態各不相同。包裝薄膜尤其需要仔細考慮，因為它細分為雙軸延伸聚丙烯(BOPP)、高密度聚苯乙烯(HDPE) 和低密度聚乙烯 (LDPE)，每種材料對遷移和透明度都有不同的限制。對於電纜電線應用而言，電氣相容性和熱穩定性是首要考慮因素；而擠出成型和射出成型則更注重加工窗口的耐久性和母粒系統的均質性。

區域對比分析揭示了美洲、歐洲、中東和非洲以及亞太地區的趨勢將如何影響供應可靠性、合規預期和商業策略。

區域趨勢將塑造供應鏈結構、監管摩擦以及製造商和買家必須應對的競爭強度。在美洲，由於地理位置接近性主要聚合物加工商，且高度重視近岸採購，因此對穩定的供應模式和可預測的物流需求日益成長。該地區的生產商往往重視卡車直達工廠的配送模式以及支援準時生產和快速配方切換的供應商夥伴關係。

競爭優勢和策略夥伴關係推動了整個艾草醯胺供應鏈的可靠性、技術差異化和快速認證。

Erucamide價值鏈中的主要企業兼具卓越的技術、靈活的供應鏈以及對品質保證的堅定承諾。投資於先進蒸餾和加氫等純化技術的市場參與企業能夠持續實現嚴格的雜質控制和可重複的產品規格，從而滿足高價值應用的需求。同樣重要的是，擁有成熟的多模態物流方案和區域倉儲設施的公司能夠快速應對需求波動和關稅相關的干擾。

為製造商和買家提供切實可行的、優先排序的策略舉措，以增強供應韌性、加速產品客製化，並在動態的貿易環境中保護利潤率。

產業領導者應優先考慮能夠增強韌性並創造商業性優勢的實際措施。首先，應實現供應商多元化，以平衡成本、地理風險和品質穩定性。對關鍵等級產品採用雙重採購模式並對區域供應商進行認證，可以減少單點故障。其次，應投資於技術合作，加速產品客製化和與加工商的共同開發，從而縮短新配方上市時間，並實現性能目標的快速迭代。

採用嚴謹的混合方法研究途徑，結合專家訪談、技術文獻綜述和供應鏈分析，檢驗Erucamide的表現和商業性趨勢。

本分析的調查方法結合了定性專家訪談、技術文獻綜述和供應鏈分析，以全面觀點Erucamide的發展趨勢。研究重點包括與負責人、製程工程師和物流專家進行討論，以了解實際應用中的限制因素和應用標準。這些討論為系統評估生產技術、操作特性和特定應用性能要求奠定了基礎。

對Erucamide在績效、合規性和供應鏈韌性方面的策略角色進行綜合分析，凸顯了跨職能決策的必要性。

Erucamide在聚合物添加劑產品組合中佔據著重要的地位，它兼顧了材料性能、加工性能和法規遵從性。全面的分析表明，效用，而每個行業領域都面臨著獨特的技術和商業性壓力，這些壓力會影響產品設計和採購選擇。相關人員使其配方策略與不斷變化的法規要求保持一致，並投資於採購多元化和技術改進，就能找到實現商業性穩定和產品差異化的清晰路徑。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將艾草醯胺加速整合到可生物分解食品包裝薄膜中，可改善其滑爽性能。
  • 市場對油菜籽衍生的生物基Erucamide的需求日益成長，這為其在永續聚合物配方中的應用提供了重要依據。
  • 埃里醯胺奈米技術塗層在提高汽車零件耐腐蝕性方面的進展
  • 日益嚴格的食品接觸法規推動了乙醇醯胺潤滑劑純度水準的提高。
  • 化學品製造商和研究機構進行新的合作，開發生物基取代乙醇醯胺。
  • 策略夥伴關係的重點是擴大利用可再生原料生產Erucamide的規模，以滿足市場需求。
  • 將先進分析技術應用於藥品包裝薄膜中Erucamide的品管

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章Erucamide市場：按應用領域分類

  • 電線電纜
  • 擠壓
  • 射出成型
  • 包裝膜
    • 雙軸延伸聚丙烯
    • 高密度聚苯乙烯
    • 低密度聚乙烯

第9章 依最終用途產業分類的Erucamide市場

  • 車
  • 建造
  • 電學
  • 鞋革業
  • 包裝
    • 軟包裝
    • 工業包裝
    • 硬包裝

第10章 依產品類型分類的Erucamide市場

  • 顆粒
  • 液體
  • 顆粒
  • 粉末

第11章Erucamide市場：依技術分類

  • 蒸餾
  • 氫化
  • 溶劑萃取

第12章Erucamide市場：按地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章Erucamide市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國Erucamide市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • BASF SE
    • Dow Inc.
    • Evonik Industries AG
    • Clariant AG
    • Lonza Group AG
    • Croda International Plc
    • Arkema SA
    • Afton Chemical Corporation
    • Mitsubishi Gas Chemical Company, Inc.
    • Oleon NV
Product Code: MRR-1A1A064C0127

The Erucamide Market is projected to grow by USD 385.39 million at a CAGR of 4.33% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 274.42 million
Estimated Year [2025] USD 286.58 million
Forecast Year [2032] USD 385.39 million
CAGR (%) 4.33%

Concise foundational orientation to erucamide chemistry, industrial utility, processing considerations, and the practical framework decision-makers need for informed actions

Erucamide has emerged as a pivotal slip agent and processing aid in polymers, lubricants, and surface modifiers, with broad relevance across manufacturing verticals. This executive summary frames erucamide's role within contemporary production environments, emphasizing its physicochemical attributes, compatibility with polyolefins, and utility in enhancing surface feel, frictional properties, and processing stability. Readers will gain a clear sense of where erucamide integrates into value chains, how it interacts with typical resin systems, and why material engineers and procurement professionals increasingly focus on its specification and sourcing.

The following content synthesizes technical characteristics with practical considerations for industrial adoption. It bridges laboratory performance with industrial-scale requirements, highlighting manufacturing variables such as melt flow behavior, additive migration, and thermal stability under common processing regimes. The intent is to orient decision-makers to the product's practical benefits and constraints, while setting a shared vocabulary for subsequent sections that address regulatory adjustments, trade environments, segmentation complexity, regional dynamics, and corporate strategies.

How evolving feedstock sources, sustainability priorities, regulatory shifts, and processing innovations are redefining erucamide applications and supply chain strategies

The erucamide landscape is shifting rapidly as raw material pathways, sustainability priorities, and downstream formulation preferences evolve in parallel. Across the value chain, sourcing strategies are adapting to feedstock volatility and increased scrutiny over lifecycle impacts, pushing formulators to reassess additive performance criteria and suppliers to enhance traceability. Advances in processing technologies and compounding approaches have expanded the effective use cases for erucamide beyond traditional slip applications, enabling improved low-temperature migration control and compatibility with advanced polyolefin blends.

Concurrently, regulatory and commercial pressures are accelerating the pursuit of greener chemistries and alternative supply networks. Brand owners are integrating additive-level transparency into their sustainability narratives, which in turn prompts processors to secure verifiable supply chains and consider secondary parameters such as biodegradability profiles and renewable feedstock sourcing. These forces intersect with technological innovation: enhanced distillation and hydrogenation routes alongside solvent extraction refinements have raised the bar for consistency and impurity control, which supports higher-value applications and longer product lifecycles. Together, these shifts are redefining how erucamide is specified, procured, and positioned within product portfolios.

How the 2025 United States tariff adjustments reshaped procurement behavior, supplier diversification, and inventory strategies across additive supply chains

United States tariff adjustments in 2025 created tangible ripple effects across sourcing strategies, supplier selection, and supply chain contingency planning. Import duties altered relative landed cost differentials for exporters and redirected procurement conversations toward domestic production resilience and diversified supplier networks. As a direct consequence, buyers reassessed long-standing supplier relationships and accelerated qualification timelines for secondary sources to preserve continuity of supply.

These tariff-driven dynamics also stimulated deeper collaboration between buyers and manufacturers to redesign procurement contracts with clauses that address duty pass-through, inventory staging, and shared risk for supply interruptions. Logistics planners adjusted inbound routing and inventory positions to reduce exposure to ports and customs treatments that incurred higher duty liabilities. At the same time, manufacturers prioritized near-shoring and investment in local compounding capabilities to minimize import dependency for critical additive volumes. The net effect emphasized operational agility: organizations that integrated tariff scenario planning into sourcing playbooks and stress-tested supplier capacity performed better in maintaining production schedules, while those reliant on a narrow set of foreign suppliers faced more acute short-term disruptions.

Actionable segmentation intelligence revealing how application, end-use industry, product type, and production technology determine erucamide suitability and supplier selection

Segmentation insights illuminate application-specific drivers and technical requirements that influence erucamide selection and formulation tactics. Based on Application, market dynamics vary between Cable & Wire, Extrusion, Injection Molding, and Packaging Films, with the latter category demanding particular attention because Packaging Films subdivide into Biaxial Oriented Polypropylene, High Density Polyethylene, and Low Density Polyethylene, each imposing distinct migration and clarity constraints. Cable & Wire applications prioritize electrical compatibility and thermal stability, whereas extrusion and injection molding emphasize processing window resilience and homogenization in masterbatch systems.

When viewed through the lens of End Use Industry, sectoral priorities further refine product specifications. Automotive applications demand thermal endurance and low-bleed profiles to maintain aesthetic and functional surfaces, while Construction markets value durability and weathering resistance. Electronics & Electrical segments require additive purity to avoid interference with sensitive components, and Footwear & Leather leverage slip and feel improvements to enhance consumer perception. The Packaging vertical, which is analyzed as Flexible Packaging, Industrial Packaging, and Rigid Packaging, places a premium on clarity, anti-blocking performance, and regulatory compliance for food contact when relevant.

Product Type segmentation clarifies handling, formulation, and dosing considerations. Granule, Liquid, Pellet, and Powder forms present distinct advantages and constraints for dosing accuracy, dispersion efficiency, and worker safety. Liquid formats facilitate rapid blending but necessitate solvent management, while granules and pellets typically offer easier handling and consistent dosing in automated compounding lines. Powder forms require enhanced dust control and dispersion technologies to achieve uniform additive distribution.

Technology choices govern production cost profile and impurity control. Distillation routes excel at delivering narrow boiling point fractions and therefore support higher-purity grades, Hydrogenation pathways reduce unsaturation-related instability and can improve color and odor profiles, and Solvent Extraction techniques offer selective removal of undesired constituents. Each technological approach yields trade-offs between capital intensity, environmental footprint, and achievable product performance, shaping supplier capabilities and the technical fit for end-use requirements.

Comparative regional analysis highlighting how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence supply reliability, compliance expectations, and commercial strategies

Regional dynamics dictate supply chain architecture, regulatory friction, and the competitive intensity that manufacturers and buyers must navigate. In the Americas, proximity to major polymer converters and a pronounced focus on near-shore sourcing drive demand for consistent supply profiles and logistics predictability. Producers in this region often emphasize truck-to-plant distribution models and supplier partnerships that support just-in-time manufacturing and rapid formulation changes.

Europe, Middle East & Africa present a diverse regulatory and market landscape where sustainability mandates and stringent product stewardship expectations shape purchasing behavior. Chemical regulations and extended producer responsibility frameworks encourage producers to highlight traceability and impurity control. In these markets, local compliance, certifications, and demonstrated lifecycle assessments play a larger role in procurement qualification than in some other regions.

Asia-Pacific encompasses varied production bases and a dense concentration of polymer processing capacity, which sustains a broad set of erucamide application opportunities. Manufacturing hubs within this region frequently leverage integrated supply chains that offer scale advantages, while regional demand exhibits rapid responsiveness to changes in consumer packaging trends and industrial expansion. Across all regions, cross-border logistics complexity, lead-time sensitivity, and differing regulatory thresholds converge to influence supplier selection and risk management strategies.

Competitive company attributes and strategic partnerships that drive reliability, technical differentiation, and faster qualification across the erucamide supply chain

Leading companies in the erucamide value chain exhibit a combination of technical excellence, supply chain flexibility, and a clear posture on quality assurance. Market participants that invest in refining technology, such as advanced distillation and hydrogenation capabilities, consistently achieve tighter impurity controls and more reproducible product specifications that appeal to high-value applications. Equally important, firms that establish multi-modal logistics options and regional warehousing can respond more rapidly to shifts in demand or tariff-related disruptions.

Strategic partnerships between additive producers and resin converters or compounders strengthen route-to-market effectiveness and shorten qualification cycles for end-users. Companies that offer formulation support, application testing, and co-development services differentiate themselves by reducing the integration friction for processors. Transparency around batch traceability, certificates of analysis, and adherence to relevant regulatory frameworks further enhances supplier credibility, especially when brand owners require verifiable supply chain information for sustainability reporting and compliance audits.

Practical and prioritized strategic moves for manufacturers and buyers to build supply resilience, accelerate product customization, and protect margins in a dynamic trade environment

Industry leaders should prioritize a set of actionable moves that enhance resilience and create commercial advantage. First, diversify supplier footprints to balance cost, geographic exposure, and quality consistency; dual-sourcing critical grades and qualifying regional suppliers reduces single-point failures. Second, invest in technical partnerships that accelerate product customization and co-development with converters, thereby shortening time-to-market for new formulations and enabling rapid iteration on performance targets.

Third, embed tariff and trade scenario planning into procurement playbooks to ensure pricing and logistics strategies remain adaptable. This involves establishing inventory buffers at strategic nodes, negotiating flexible contract terms with suppliers, and exploring bonded or free-trade arrangements where appropriate. Fourth, elevate documentation and traceability practices to support regulatory compliance and sustainability narratives; clear certificates of analysis, material origin data, and process transparency strengthen customer trust and facilitate market access in stricter regulatory environments. Finally, pursue targeted capital investment in refining and purification technologies to improve grade consistency and enable movement into higher-margin applications that demand low impurity and stable migration behavior.

Rigorous mixed-method research approach integrating expert interviews, technical literature review, and supply chain mapping to validate erucamide performance and commercial dynamics

The research methodology underpinning this analysis combined qualitative expert interviews, technical literature review, and supply chain mapping to generate a comprehensive perspective on erucamide dynamics. Primary engagements included discussions with formulators, procurement leads, process engineers, and logistics specialists to capture real-world constraints and adoption criteria. These conversations informed a structured assessment of production technologies, handling characteristics, and application-specific performance requirements.

Secondary research consolidated publicly available technical papers, regulatory documents, and patent filings to validate observed trends and identify technological maturation in distillation, hydrogenation, and solvent extraction processes. Supply chain mapping integrated customs data patterns and logistics route analysis to surface sensitivity points related to tariff changes and regional lead times. Throughout, analytical rigor focused on triangulating evidence across sources to ensure the conclusions reflect operational realities and not isolated anecdotes.

Synthesis of erucamide's strategic role across performance, compliance, and supply resilience that underscores the need for integrated cross-functional decision-making

Erucamide occupies a critical niche in polymer additive portfolios where material performance, processing behavior, and regulatory compliance intersect. The cumulative picture shows a material whose utility extends across multiple industrial domains, each with distinct technical and commercial pressures that influence product design and sourcing choices. Stakeholders that align formulation strategy with evolving regulatory expectations and invest in diversified sourcing and technological refinement will find clearer pathways to commercial stability and product differentiation.

Looking ahead, the interplay between supply chain resilience, technological advancement, and sustainability commitments will determine which participants capture the most value. Organizations that treat additive strategy as integral to product performance and supply continuity-rather than as a low-touch procurement item-will achieve stronger outcomes in both operational reliability and end-customer satisfaction. This conclusion underscores the importance of cross-functional alignment among R&D, procurement, and commercial teams to translate insight into action.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Escalating integration of erucamide in biodegradable food packaging films to enhance slip properties
  • 5.2. Rising demand for bio-based erucamide derived from rapeseed oil for sustainable polymer formulations
  • 5.3. Advancements in erucamide nanotechnology coatings for enhanced corrosion resistance in automotive parts
  • 5.4. Impact of stringent food contact regulations driving innovations in erucamide slip agent purity levels
  • 5.5. Emerging collaborations between chemical manufacturers and research institutes for bio-derived erucamide alternatives
  • 5.6. Strategic partnerships focusing on scaling production of erucamide from renewable feedstocks to meet market demand
  • 5.7. Integration of advanced analytical techniques for erucamide quality control in pharmaceutical packaging films

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Erucamide Market, by Application

  • 8.1. Cable & Wire
  • 8.2. Extrusion
  • 8.3. Injection Molding
  • 8.4. Packaging Films
    • 8.4.1. Biaxial Oriented Polypropylene
    • 8.4.2. High Density Polyethylene
    • 8.4.3. Low Density Polyethylene

9. Erucamide Market, by End Use Industry

  • 9.1. Automotive
  • 9.2. Construction
  • 9.3. Electronics & Electrical
  • 9.4. Footwear & Leather
  • 9.5. Packaging
    • 9.5.1. Flexible Packaging
    • 9.5.2. Industrial Packaging
    • 9.5.3. Rigid Packaging

10. Erucamide Market, by Product Type

  • 10.1. Granule
  • 10.2. Liquid
  • 10.3. Pellet
  • 10.4. Powder

11. Erucamide Market, by Technology

  • 11.1. Distillation
  • 11.2. Hydrogenation
  • 11.3. Solvent Extraction

12. Erucamide Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Erucamide Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Erucamide Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. BASF SE
    • 15.3.2. Dow Inc.
    • 15.3.3. Evonik Industries AG
    • 15.3.4. Clariant AG
    • 15.3.5. Lonza Group AG
    • 15.3.6. Croda International Plc
    • 15.3.7. Arkema S.A.
    • 15.3.8. Afton Chemical Corporation
    • 15.3.9. Mitsubishi Gas Chemical Company, Inc.
    • 15.3.10. Oleon NV

LIST OF FIGURES

  • FIGURE 1. GLOBAL ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ERUCAMIDE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ERUCAMIDE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ERUCAMIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ERUCAMIDE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ERUCAMIDE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ERUCAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ERUCAMIDE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ERUCAMIDE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ERUCAMIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ERUCAMIDE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ERUCAMIDE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ERUCAMIDE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ERUCAMIDE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS ERUCAMIDE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS ERUCAMIDE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 226. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 241. AFRICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 242. AFRICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ERUCAMIDE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ERUCAMIDE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. ASEAN ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 270. ASEAN ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 275. ASEAN ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. ASEAN ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. GCC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GCC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GCC ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. GCC ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. GCC ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 284. GCC ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 285. GCC ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GCC ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GCC ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 288. GCC ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 289. GCC ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. GCC ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. GCC ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. GCC ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. BRICS ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. BRICS ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. BRICS ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 312. BRICS ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 317. BRICS ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. BRICS ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 321. G7 ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 322. G7 ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 323. G7 ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. G7 ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. G7 ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 326. G7 ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 327. G7 ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 328. G7 ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 329. G7 ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 330. G7 ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 331. G7 ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. G7 ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. G7 ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 334. G7 ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 335. NATO ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 336. NATO ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 337. NATO ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. NATO ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 339. NATO ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 340. NATO ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 341. NATO ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 342. NATO ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 343. NATO ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 344. NATO ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 345. NATO ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. NATO ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. NATO ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 348. NATO ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 349. GLOBAL ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 350. GLOBAL ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 351. UNITED STATES ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 352. UNITED STATES ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 353. UNITED STATES ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 354. UNITED STATES ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 355. UNITED STATES ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 356. UNITED STATES ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 357. UNITED STATES ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 358. UNITED STATES ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 359. UNITED STATES ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 360. UNITED STATES ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 361. UNITED STATES ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 362. UNITED STATES ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 363. CANADA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 364. CANADA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 365. CANADA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2024 (USD MILLION)
  • TABLE 366. CANADA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2025-2032 (USD MILLION)
  • TABLE 367. CANADA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 368. CANADA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 369. CANADA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 370. CANADA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 371. CANADA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 372. CANADA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 373. CANADA ERUCAMIDE MARKET S